Candida resistance study pulled before it began
NCT ID NCT07422194
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to learn more about different types of Candida fungus that cause serious bloodstream infections, and how they become resistant to medicines. The researchers planned to study samples from adult patients to track which species were most common and how they resisted treatment. However, the study was withdrawn before any patients were enrolled, so no information was collected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Pavia, 27100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a quick PCR test speed up lifesaving fungal infection diagnosis?
- Blood biomarkers may let ICU patients stop antifungals earlier
- Could 7 days of antifungals be enough for kids with blood infections?
- New antifungal drug's belly penetration tested in ICU patients
- New blood tests could speed up detection of deadly fungal infections
- New drug could shield transplant patients from deadly fungal infections